Invida plans to acquire Shalaks PharmaIllustrative image – not actual.
Singapore-based pharmaceuticals company Invida is planning to acquire New Delhi's Shalaks Pharmaceuticals.

The company will acquire Shalaks Pharma for $25 million (approx Rs 125 crore). Shalaks manufactures and markets prescription and OTC skincare products like sunscreen lotions, skin rash creams, soaps and cosmetics.
← All latest storiesBack to top →